ArticleClinical and translational radiation oncology2024

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence.

Sebastian M Christ et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.